Stay updated on Elranatamab vs Lenalidomide Post-Transplant Clinical Trial
Sign up to get notified when there's something new on the Elranatamab vs Lenalidomide Post-Transplant Clinical Trial page.
![Latest website image capture](/pages/_next/image?url=https%3A%2F%2Fs3.us-west-2.amazonaws.com%2Fvp-files-ore%2Fresources%2F12months%2FboPgo7PxJ3JpXuzatIeqIY_LC5M.uncropped.jpg&w=3840&q=75)
Latest updates to the Elranatamab vs Lenalidomide Post-Transplant Clinical Trial page
- ChecktodayNo Change Detected
- CheckyesterdayNo Change Detected
- Check2 days agoNo Change Detected
- Check4 days agoNo Change Detected
- Check5 days agoChange DetectedThe website has been updated to version 2.10.0, adding two more study numbers and indicating that the study now has 216 locations, while the previous version 2.9.7 has been removed.SummaryDifference0.3%
- Check8 days agoChange DetectedThe website now displays the actual last update posted instead of an estimated time, providing more accurate information to users.SummaryDifference0.0%
- Check9 days agoChange DetectedThe website has added new recruiting hospitals in Brazil, Japan, and Switzerland, with the latest update posted on July 15, 2024.SummaryDifference1.0%
- Check11 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.0%
- Check25 days agoChange DetectedThe value of Last Update Posted (Estimated) Revision has changed from v2.9.5 to v2.9.6, indicating an update in the study record for the clinical trial comparing Elranatamab versus Lenalidomide in patients with newly diagnosed multiple myeloma after transplant.SummaryDifference0.1%
- Check28 days agoChange DetectedThe value of the study record has been updated to reflect a Phase 3 study comparing Elranatamab versus Lenalidomide in patients with newly diagnosed Multiple Myeloma after undergoing autologous stem cell transplant. The last update was posted on 2024-06-28 with a revision to v2.9.5.SummaryDifference2%
Stay in the know with updates to Elranatamab vs Lenalidomide Post-Transplant Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Elranatamab vs Lenalidomide Post-Transplant Clinical Trial page.